Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden

European Journal of Cancer Prevention

Volumn 21, Issue 3, 2012, Pages 281-288

  Shu, Xiaochen ^a   Sundquist, Kristina ^a   Sundquist, Jan ^a,b   Hemminki, Kari ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

birth cohort; cancer of unknown primary; causes of death; incidence; survival

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; AUTOPSY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CAUSE OF DEATH; FEMALE; FINLAND; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; SWEDEN; UNDIFFERENTIATED CARCINOMA;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; NORWAY; REGISTRIES; SURVIVAL RATE; SWEDEN; TIME FACTORS;

EID: 84859424945     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834c9ceb     Document Type: Article

References (25)

1. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P (1994). Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272-1280. (Pubitemid 24173944)
2. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN (1995). Analysis of a diagnostic strategy for patients with suspected tumours of unknown origin. J Clin Oncol 13:2094-2103.
3. Ayoub JP, Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL (1998). Unknown primary tumors metastatic to liver. J Clin Oncol 16:2105-2112. (Pubitemid 28265047)
4. Barlow L,Westergren K, Holmberg L, Talback M (2009). The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol 48:27-33.
5. Breslow NE, Day NE (1987). Statistical methods in cancer research. The design and analysis of cohort studies. Vol 2 Lyon: IARC Press.
6. Briasoulis E, Pavlidis N (1997). Cancer of unknown primary origin. Oncologist 2:142-152. (Pubitemid 27263946)
7. Centre for Epidemiology (2009). Cancer Incidence in Sweden 2008. Stockholm, Sweden: National Board of Health and Welfare.
8. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. (2007). Cancer incidence in five continents, Vol IX. Lyon: IARC: IARC Scientific Publications, No.160.
9. Curtin LR, Klein RJ (1995). Direct standardization (age-adjusted death rates). Healthy People 2000 Stat Notes 6:1-10.
10. Greco FA, Gray J, Burris HA 3rd, Erland JB, Morrissey LH, Hainsworth JD (2001). Taxane-based chemotherapy for patients with carcinoma of unknown primary site. Cancer J 7:203-212.
11. Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL (1999). Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 5:3403-3410.
12. Kobayashi T, Koizumi T, Kitaguchi A, Hatayama O, Tsushima K, Urushihata K, et al. (2009). Cisplatin plus docetaxel chemotherapy for thoracic lymph node metastasis from cancer of unknown primary: experience of three cases. Case Rep Oncol 2:84-91.
13. Lazaridis G, Pentheroudakis G, Fountzilas G, Pavlidis N (2008). Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature. Cancer Treat Rev 34:693-700.
14. Levi F, Te VC, Erler G, Randimbison L, La Vecchia C (2002). Epidemiology of unknown primary tumours. Eur J Cancer 38:1810-1812.
15. Lindström P, Janzon L, Sternby NH (1997). Declining autopsy rate in Sweden: a study of causes and consequences in Malmö, Sweden. J Intern Med 242:157-165. (Pubitemid 27351614)
16. Lunetta P, Lounamaa A, Sihvonen S (2007). Surveillance of injury-related deaths: medicolegal autopsy rates and trends in Finland. Inj Prev 13:282-284.
17. Matsunami K, Imai A, Tamaya T, Takagi H, Noda K (1999). Brain metastasis as first manifestation of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 82:81-83. (Pubitemid 29042220)
18. Molina Garrido MJ, Mora Rufete A, Guillen Ponce C, Maria Escalante S, Carrato Mena A (2006). Skin metastases as first manifestation of lung cancer. Clin Transl Oncol 8:616-617.
19. Pentheroudakis G, Stoyianni A, Pavlidis N (2011). Cancer of unknown primary patients with midline nodal distribution: midway between poor and favourable prognosis? Cancer Treat Rev 37:120-126.
20. Randen M, Rutqvist LE, Johansson H (2009). Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007. Acta Oncol 48:915-920.
21. Storey JA, Torti FM (2007). Bone metastases in prostate cancer: a targeted approach. Curr Opin Oncol 19:254-258. (Pubitemid 46597486)
22. Svensson E, Moger TA, Tretli S, Aalen OO, Grotmol T (2006). Frailty modelling of colorectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort. Eur J Epidemiol 21:587-593. (Pubitemid 44546620)
23. Trivanovic D, Petkovic M, Stimac D (2009). New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis. Clin Oncol (R Coll Radiol) 21:43-48.
24. Van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF (2002). Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 38:409-413. (Pubitemid 34121969)
25. Williams B, Lacy PS, Yan P, Hwee CN, Liang C, Ting CM (2011). Development and validation of a novel method to derive central aortic systolic pressure from the radial pressure waveform using an N-point moving average method. J Am Coll Cardiol 57:951-961.